Literature DB >> 31764723

Racial Disparities in Postpartum Pain Management.

Nevert Badreldin1, William A Grobman, Lynn M Yee.   

Abstract

OBJECTIVE: To evaluate racial and ethnic differences in women's postpartum pain scores, inpatient opioid administration, and discharge opioid prescriptions.
METHODS: We conducted a retrospective cohort study of all deliveries at a single high-volume tertiary care center from December 1, 2015, through November 30, 2016. Women were included if they self-identified as non-Hispanic white, non-Hispanic black, or Hispanic; were at least 18 years of age; and did not have documented allergies to nonsteroidal antiinflammatory drugs or morphine. Medical records were queried for three outcomes: 1) patient-reported postpartum pain score (on a scale of 0-10) at discharge (dichotomized less than 5 or 5 or higher), 2) inpatient opioid dosing during postpartum hospitalization (reported as morphine milligram equivalents [MMEs] per postpartum day), and 3) receipt of an opioid prescription at discharge. The associations between each of these outcomes and maternal race-ethnicity were assessed using multivariable logistic regression models with random effects to account for clustering by discharge physician. A sensitivity analysis was conducted in which women of different race and ethnicity were matched using propensity scores.
RESULTS: A total of 9,900 postpartum women were eligible for analysis. Compared with non-Hispanic white women, Hispanic and non-Hispanic black women had significantly greater odds of reporting a pain score of 5 or higher (adjusted odds ratio [aOR] 1.61, 95% 1.26-2.06 and aOR 2.18, 95% 1.63-2.91, respectively) but received significantly fewer inpatient MMEs/d (adjusted β -5.03, 95% CI -6.91 to -3.15, and adjusted β -3.54, 95% CI -5.88 to -1.20, respectively). Additionally, Hispanic and non-Hispanic black women were significantly less likely to receive an opioid prescription at discharge (aOR 0.80, 95% CI 0.67 to -0.96 and aOR 0.78, 95% CI 0.62-0.98) compared with non-Hispanic white women. Results of the propensity score analysis largely corroborated those of the primary analysis, with the exception that the difference in inpatient MMEs/d between non-Hispanic white and non-Hispanic black women did not reach statistical significance.
CONCLUSION: Hispanic and non-Hispanic black women experience disparities in pain management in the postpartum setting that cannot be explained by less perceived pain.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31764723      PMCID: PMC6905121          DOI: 10.1097/AOG.0000000000003561

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  16 in total

1.  Racial and ethnic disparities in neuraxial labor analgesia.

Authors:  Paloma Toledo; Jinglu Sun; William A Grobman; Cynthia A Wong; Joe Feinglass; Romana Hasnain-Wynia
Journal:  Anesth Analg       Date:  2011-11-10       Impact factor: 5.108

2.  False alarms and pseudo-epidemics: the limitations of observational epidemiology.

Authors:  David A Grimes; Kenneth F Schulz
Journal:  Obstet Gynecol       Date:  2012-10       Impact factor: 7.661

3.  Frequency of and factors associated with severe maternal morbidity.

Authors:  William A Grobman; Jennifer L Bailit; Madeline Murguia Rice; Ronald J Wapner; Uma M Reddy; Michael W Varner; John M Thorp; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Alan T Tita; George Saade; Yoram Sorokin; Dwight J Rouse; Sean C Blackwell; Jorge E Tolosa; J Peter Van Dorsten
Journal:  Obstet Gynecol       Date:  2014-04       Impact factor: 7.661

4.  Racial differences in the use of epidural analgesia for labor.

Authors:  Laurent G Glance; Richard Wissler; Christopher Glantz; Turner M Osler; Dana B Mukamel; Andrew W Dick
Journal:  Anesthesiology       Date:  2007-01       Impact factor: 7.892

5.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  MMWR Recomm Rep       Date:  2016-03-18

Review 6.  Racial and ethnic disparities in obstetric anesthesia.

Authors:  Elizabeth M S Lange; Suman Rao; Paloma Toledo
Journal:  Semin Perinatol       Date:  2017-06-07       Impact factor: 3.300

7.  Analgesic Access for Acute Abdominal Pain in the Emergency Department Among Racial/Ethnic Minority Patients: A Nationwide Examination.

Authors:  Adil A Shah; Cheryl K Zogg; Syed Nabeel Zafar; Eric B Schneider; Lisa A Cooper; Alyssa B Chapital; Susan M Peterson; Joaquim M Havens; Roland J Thorpe; Debra L Roter; Renan C Castillo; Ali Salim; Adil H Haider
Journal:  Med Care       Date:  2015-12       Impact factor: 2.983

8.  Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.

Authors:  Jayani Jayawardhana; Amanda J Abraham; Matthew Perri
Journal:  J Manag Care Spec Pharm       Date:  2018-09

9.  Racial differences in opioid prescribing for children in the United States.

Authors:  Cornelius B Groenewald; Jennifer A Rabbitts; Elizabeth E Hansen; Tonya M Palermo
Journal:  Pain       Date:  2018-10       Impact factor: 7.926

10.  Cut-Off Points for Mild, Moderate, and Severe Pain on the Numeric Rating Scale for Pain in Patients with Chronic Musculoskeletal Pain: Variability and Influence of Sex and Catastrophizing.

Authors:  Anne M Boonstra; Roy E Stewart; Albère J A Köke; René F A Oosterwijk; Jeannette L Swaan; Karlein M G Schreurs; Henrica R Schiphorst Preuper
Journal:  Front Psychol       Date:  2016-09-30
View more
  17 in total

1.  Validation of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool with the WHO alcohol, smoking, and substance Involvement screening test (ASSIST).

Authors:  Gentry Carter; Ziji Yu; M Aryana Bryan; Jennifer L Brown; T Winhusen; Gerald Cochran
Journal:  Addict Behav       Date:  2021-11-10       Impact factor: 3.913

2.  Peripartum racial/ethnic disparities.

Authors:  Elizabeth M S Lange; Paloma Toledo
Journal:  Int Anesthesiol Clin       Date:  2021-07-01

3.  Patient Experience with Postpartum Pain Management in the Face of the Opioid Crisis.

Authors:  Karolina Leziak; Lynn M Yee; William A Grobman; Nevert Badreldin
Journal:  J Midwifery Womens Health       Date:  2021-03-04       Impact factor: 2.891

4.  Bioethics, Race, and Contempt.

Authors:  Yolonda Yvette Wilson
Journal:  J Bioeth Inq       Date:  2021-01-07       Impact factor: 1.352

5.  Investigating the Use of a Serious Game to Improve Opioid Safety Awareness Among Adolescents: Quantitative Study.

Authors:  Olufunmilola Abraham; Claire Rosenberger; Kathleen Tierney; Jen Birstler
Journal:  JMIR Serious Games       Date:  2021-12-23       Impact factor: 4.143

6.  The Association between Implementation of an Enhanced Recovery after Cesarean Pathway with Standardized Discharge Prescriptions and Opioid Use and Pain Experience after Cesarean Delivery.

Authors:  Jennifer A McCoy; Sarah Gutman; Rebecca F Hamm; Sindhu K Srinivas
Journal:  Am J Perinatol       Date:  2021-07-19       Impact factor: 1.862

7.  Stopping the revolving door: An exploratory analysis of health care super-utilization in gynecologic oncology.

Authors:  Catherine N Zivanov; Annie Apple; Alaina J Brown; Marc A Robinson; Lauren S Prescott
Journal:  Gynecol Oncol Rep       Date:  2021-05-19

8.  The impact of race on postpartum opioid prescribing practices: a retrospective cohort study.

Authors:  Tyler R McKinnish; Adam K Lewkowitz; Ebony B Carter; Ashley E Veade
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-22       Impact factor: 3.007

9.  Cardioprotective medication use in Black and white breast cancer survivors.

Authors:  Arnethea L Sutton; Ashley S Felix; Dipankar Bandyopadhyay; Reuben Retnam; William G Hundley; Vanessa B Sheppard
Journal:  Breast Cancer Res Treat       Date:  2021-04-02       Impact factor: 4.624

10.  Chronic Noncancer Pain Management and Systemic Racism: Time to Move Toward Equal Care Standards.

Authors:  Malini Ghoshal; Hannah Shapiro; Knox Todd; Michael E Schatman
Journal:  J Pain Res       Date:  2020-11-06       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.